Protease inhibitors represent a promising
therapeutic option for
the treatment of parasitic diseases such as malaria and human African
trypanosomiasis. Falcitidin was the first member of a new class of
inhibitors of falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum. Using a metabolomics dataset
of 25 Chitinophaga strains for molecular networking
enabled identification of over 30 natural analogues of falcitidin.
Based on MS/MS spectra, they vary in their amino acid chain length,
sequence, acyl residue, and C-terminal functionalization; therefore,
they were grouped into the four falcitidin peptide families A–D.
The isolation, characterization, and absolute structure elucidation
of two falcitidin-related pentapeptide aldehyde analogues by extensive
MS/MS spectrometry and NMR spectroscopy in combination with advanced
Marfey’s analysis was in agreement with the in silico analysis
of the corresponding biosynthetic gene cluster. Total synthesis of
chosen pentapeptide analogues followed by in vitro testing against
a panel of proteases revealed selective parasitic cysteine protease
inhibition and, additionally, low-micromolar inhibition of α-chymotrypsin.
The pentapeptides investigated here showed superior inhibitory activity
compared to falcitidin.